Name: SBCWW Income Statement - Sbc Medical Group. Holdings. Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

SBCWW - Sbc Medical Group. Holdings. Inc.

USD | NASDAQ | Healthcare

SBCWW Income Statement - Sbc Medical Group. Holdings. Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q3 FY 22	Q2 FY 22
Revenues
Revenues	43.1	39.6	43.4	43.4	47.3	44.4	53.1	53.1	54.8	-	47.3	-	-	-	-
Cost of Revenue	12.7	10.6	12.7	13.3	9.6	10.5	9.8	13.7	15.3	-	13.8	-	-	-	-
Gross Profit	30.3	28.9	30.6	30.0	37.7	33.9	43.2	39.4	39.5	-	33.5	-	-	-	-
Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income
Operating Income	17.7	12.8	15.9	14.6	24.2	4.7	13.8	27.3	24.5	51.5	20.0	(0.5)	(0.4)	(0.3)
Non-Operating
Interest Income	0.1	(0.0)	0.1	0.0	0.1	(0.0)	0.0	0.0	0.0	-	0.0	-	-	-	-
Tax & Net
Income Tax Expense	7.5	4.3	5.7	11.1	10.0	(0.5)	10.3	8.5	8.5	21.6	13.0	0.2	0.3	0.1	-
Per Share
EPS Basic	0.11	-	0.12	0.02	0.21	-	0.03	0.20	0.20	-	0.09	-	-	-	0.00
EPS Diluted
Supplementary Data
EBITDA	18.4	13.9	16.3	15.1	24.8	6.2	14.6	27.9	25.5	-	21.9	-	-	-	-
EBIT

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023
Revenues
Revenues	169.3	173.6	205.4	193.5
Cost of Revenue	49.4	46.3	49.4	56.2
Gross Profit	119.9	127.3	156.1	137.3
Operating Expenses
Research & Development	-	-	-	-
Selling General & Administrative	58.9	59.8	57.7	66.2
Selling & Marketing	-	-	-
Operating Income
Operating Income	61.0	67.5	70.3	70.7
Non-Operating
Interest Income	0.3	0.2	0.0	0.1
Interest Expense	0.3	0.1	0.0	0.0
Income From Equity Investments	-	-	-
Tax & Net
Income Tax Expense	28.6	31.0	26.8	35.0
Net Income From Continuing Ops	40.9	51.0	46.7	38.6
Net Income From Discontinued Ops	-	-	-
Per Share
EPS Basic	0.40	0.50	0.48	0.42
EPS Diluted	0.40	0.50	0.48	0.42
Shares Basic	102.6	103.0	96.6	94.2
Supplementary Data
EBITDA	63.7	70.2	74.1	82.9
EBIT	61.0	67.5	70.3	70.7

Source: SEC EDGAR company filings. Figures as reported (US GAAP)